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Nowadays, ‘Difficult to see a doctor, Housing difficulties, School difficulties’is the
new ‘Three big mountains’that placed in front of us. The Medical care, housing and
education are three of the people's livelihood, which is directly related to the interests
of everyone. The three major aspects of reform are in progress with Reform and
opening up in the past three decades, but compared to China's rapid economic
development, the reform process seems slow and ineffective. In health care, the State
Council reported ‘China's medical reform was not successful.’
Since China’s Reform and opening up in 1978, the pharmaceutical industry have an
average annual growth rate of 16.6%, becoming one of the fastest-growing sectors in
national economy, it’s faster than the world's leading pharmaceutical major countries.
Jiang Su HENG RUI Medicine Co., ltd. as a combination of scientific research,
production and sales of large listed companies of Chinese medicine, is the largest
Anti-neoplastic drugs research and production base, Anti-neoplastic sales ranked first
in China, the national fixed-point anesthesia pharmaceutical manufacturers. There are
more than 60 companies listed in the domestic pharmaceutical manufacturing, only
5-6 companies own the market value more than 10 billion. HENG RUI Medicine is
the highest market value of the domestic market, better development of medical
manufacturing companies. Therefore, this article selected it as a specific case, through
the development process of the company, the operating situation and financial
statements analysis, research the value of their investment.
In this paper, we firstly analysis the macro-economic environment through some
main variables; followed analysis the characteristics and current status of Chinese
medicine manufacturing industry; Finally with the operations and key financial
indicators of Jiangsu HENG RUI Medicine Co., ltd. through appropriate financial
forecast, using three-stage free cash flow model and P/E method to assess the
enterprise value. In this paper, data derived from company annual reports, government
web sites and related research institutions, the study found that HENG RUI Medicine
is a well-run enterprise and good business prospects. Is therefore attracts the
investors’attention, to buy and to be long-term holders, to share the benefits of rapid
growths.
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我们从上图可以看出，除了 2008 年外，近十年来 GDP 逐步上升，到 2007 年
达到 13%。2008 年的 GDP 没能延续前几年的增长趋势，而是从 2007 年 13%猛降
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